Novartis receives three new FDA approvals for the expanded use of Ilaris for patients with rare Periodic Fever Syndrome conditions

Novartis receives three new FDA approvals for the expanded use of Ilaris for patients with rare Periodic Fever Syndrome conditions

Sep 23, 2016
Source URL: https://qa1.novartis.us/us-en/news/media-releases/novartis-receives-three-new-fda-approvals-expanded-use-ilaris-patients-rare-periodic-fever-syndrome-conditions-0

List of links present in page
  1. https://qa1.novartis.us/us-en/us-en/news/media-releases/novartis-receives-three-new-fda-approvals-expanded-use-ilaris-patients-rare-periodic-fever-syndrome-conditions-0